Joelle Campestrini

Pharmacokinetics and Pharmacodynamics of Vildagliptin??in??Patients?? with Type??2??Diabetes??Mellitus

Yanling He, Denise Serra, Yibin Wang et al. · Clinical Pharmacokinetics · 2007 · 103 citations

Medicine, Diabetes, Pharmacokinetics +1

The Absolute Oral Bioavailability and??Population-Based Pharmacokinetic Modelling of a Novel Dipeptidylpeptidase-IV Inhibitor, Vildagliptin, in Healthy Volunteers

Yanling He, Brian M. Sadler, Ron Sabo et al. · Clinical Pharmacokinetics · 2007 · 74 citations

Pharmacokinetic Modeling, Novel Dipeptidylpeptidase-iv Inhibitor, Healthy Volunteers +8

Effect of food on the bioavailability of triclabendazole in patients with fascioliasis

J. B. Lecaillon, J. Godbillon, Joelle Campestrini et al. · British Journal of Clinical Pharmacology · 1998 · 66 citations · Full text

The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers

Yanling He, Ron Sabo, Joelle Campestrini et al. · British Journal of Clinical Pharmacology · 2007 · 65 citations · Full text

The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin

Yanling He, Ron Sabo, Joelle Campestrini et al. · European Journal of Clinical Pharmacology · 2007 · 64 citations

Liver Physiology, Pharmacology, Hepatic Impairment +8